- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04709367
Characterization of Residual Limb Volume Changes in Transfemoral Amputees
January 12, 2021 updated by: Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro
Characterization of Residual Limb Volume Changes in Transfemoral Amputees: Descriptive Prospective Longitudinal Observational Study.
This study quantifies residual limb volume fluctuations affecting transfemoral amputees due to the prosthesis doffing, physical activity, and testing time.
Study Overview
Detailed Description
The first test session aims at measuring residual limb volume at 7 time-points, with 10 minute intervals, after prosthesis doffing.
This allows for evaluating the time required for volume stabilization after prosthesis removal, for each amputee.
In subsequent sessions, 16 residual limb scans in a day for each amputee are captured to evaluate volume changes due to prosthesis removal and physical activity, in two times per day (one in the morning, one in the afternoon).
These measurements are repeated in three different days, a week apart from each other, for a total of 48 scans for each amputee.
Study Type
Observational
Enrollment (Actual)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
BO
-
Bologna, BO, Italy, 40054
- INAIL Prosthesis Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
transfemoral amputees
Description
Inclusion Criteria:
- Stabilized (i.e., time since amputation > 18 months) transfemoral amputees
- Age between 18 and 65 years old
- Subjects able to safely perform the physical tasks required in the experimental protocol
- Subjects provided with prostheses
Exclusion Criteria:
- Denial of informed consent to participate in the study
- Inability to maintain the required position during the 3D scanning for at least 5 minutes
- Concomitant general or localized comorbidities / disabilities, which may interfere with the study
- Pathological conditions affecting the residual limb
- Allergy / sensitivity with polydimethylsiloxane (PDMS)
- Pathological cardiopulmonary / cardiovascular conditions
- Pregnancy or breastfeeding
- Presence of psychiatric co-morbidities
- Presence of cognitive deficits which may compromise the understanding of the required tasks
- Difficulty in understanding the Italian language
- Insufficient degree of collaboration
- Consumption of alcohol or diuretics before tests
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Residual limb volume changes
Time Frame: The protocol consisted of four test sessions in four different days for an overall duration of 3 weeks
|
Residual limb volume changes due to prosthesis doffing, physical activity, and testing time are measured by a proper experimental set-up, including a 3D metrology-grade optical scanner.
|
The protocol consisted of four test sessions in four different days for an overall duration of 3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pressure distribution at the prosthetic socket - residual limb interface
Time Frame: The protocol consisted of four test sessions in four different days for an overall duration of 3 weeks
|
Pressure distributions at the residual limb/ socket interface are measured by the F-Socket Pressure Measurement System, during:
|
The protocol consisted of four test sessions in four different days for an overall duration of 3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Emanuele Gruppioni, INAIL Prosthesis Centre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 11, 2018
Primary Completion (ACTUAL)
August 31, 2020
Study Completion (ACTUAL)
September 30, 2020
Study Registration Dates
First Submitted
January 12, 2021
First Submitted That Met QC Criteria
January 12, 2021
First Posted (ACTUAL)
January 14, 2021
Study Record Updates
Last Update Posted (ACTUAL)
January 14, 2021
Last Update Submitted That Met QC Criteria
January 12, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- P-PPRAI1/2-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amputation Stump
-
Massachusetts Institute of TechnologyNational Institute for Biomedical Imaging and Bioengineering (NIBIB)CompletedAmputation StumpUnited States, Mexico
-
Brooke Army Medical CenterUniversity of WashingtonRecruiting
-
Helsinki University Central HospitalCompletedAmputation StumpFinland
-
Jason HighsmithFlorida High Tech Corridor Council; Otto Bock HealthcareCompletedOther and Unspecified Complications of Amputation StumpUnited States
-
London Health Sciences CentreUnknownInfection | Amputation Wound | Amputation Stump Complication | Amputation Stump; Infection
-
Baskent UniversityAnkara Yildirim Beyazıt University; Universtiy of Health Sciences - Gülhane...RecruitingAmputation | Amputation Stump | Amputees | Amputation of Knee | VascularisationTurkey
-
Liberating Technologies, Inc.Vivonics, Inc.CompletedLower Limb Amputation Below Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation StumpUnited States
-
Liberating Technologies, Inc.Vivonics, Inc.CompletedAmputation | Prosthesis | Prosthesis User | Amputation Stump | Amputees | Lower Limb DeformityUnited States
-
University of SaskatchewanUniversity of ManitobaCompletedAmputation | Motor Activity | Phantom Limb | Amputation StumpCanada
-
University of California, San DiegoNational Institute of General Medical Sciences (NIGMS); Summit MedicalCompletedAmputation | Phantom Limb | Stump PainUnited States
Clinical Trials on 3D optical scan
-
Zuyderland Medisch CentrumUnknown
-
University of HullUniversity of DundeeTerminated
-
Zuyderland Medisch CentrumUnknownPectus ExcavatumNetherlands
-
Advanced Scanners Inc.RecruitingScoliosis | Spinal Stenosis | Spinal Fusion | SpondylolisthesisUnited States
-
Advanced Scanners Inc.RecruitingSciatica | Scoliosis | Spinal Fusion | SpondylolisthesisUnited States
-
Advanced Scanners Inc.Enrolling by invitation
-
University Hospitals Bristol and Weston NHS Foundation...Bosum Buddies; Friends of the Bristol Haematology and Oncology CentreTerminated
-
University of CoimbraCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedBone Microarchitecture